BioPharmSignal logoBioPharmSignal

Biotech News

Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets

Accelerate Diagnostics (AXDX)Accelerate DiagnosticsCompany update

AXDX (AXDX) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is axdx.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

AXDXAccelerate Diagnostics2025-03-21 17:52 EST

Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance

AXDXAccelerate Diagnostics2025-03-21 12:30 EST

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results

TTOOT2 Biosystems2024-10-07 13:05 EST

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

DGXQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

BIAFbioAffinity Technologies, Inc.2026-07-22 12:08 EST

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD

DGXQuest Diagnostics2026-04-21 10:47 EST

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

FLGTFulgent Genetics, Inc.2025-12-22 21:10 EST

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

TTOOT2 Biosystems2024-10-08 13:00 EST

T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

VRAXVirax Biolabs2026-07-16 11:30 EST

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

BJDXBluejay Diagnostics2026-06-02 10:30 EST

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

View all latest news

Accelerate Diagnostics

Accelerate Diagnostics was a diagnostics company focused on rapid infectious-disease testing before its restructuring and decline. Its platform aimed to speed up bacterial identification and susceptibility testing.

Recent company news

AXDXAccelerate Diagnostics2025-05-08 13:00 EST

Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets

AXDXAccelerate Diagnostics2025-03-21 17:52 EST

Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance

AXDXAccelerate Diagnostics2025-03-21 12:30 EST

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results

AXDXAccelerate Diagnostics2025-01-10 21:05 EST

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

AXDXAccelerate Diagnostics2024-11-07 21:05 EST

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
MedTech
Location
United States